Hospital Virgen del Puerto-ko ikertzaileekin lankidetzan egindako argitalpenak (15)

2024

  1. Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis

    HemaSphere

  2. The prognostic impact of non-driver gene mutations and variant allele frequency in primary myelofibrosis

    American Journal of Hematology

2016

  1. A path analysis of patient dependence and caregiver burden in Alzheimer's disease

    International Psychogeriatrics, Vol. 28, Núm. 7, pp. 1133-1141

  2. Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis

    Blood, Vol. 127, Núm. 24, pp. 3035-3039

2015

  1. Prevalence of fractures in women with rheumatoid arthritis and/or systemic lupus erythematosus on chronic glucocorticoid therapy Epidemiology of musculoskeletal disorders

    BMC Musculoskeletal Disorders, Vol. 16, Núm. 1

  2. The cellular origin and malignant transformation of Waldenström macroglobulinemia

    Blood, Vol. 125, Núm. 15, pp. 2370-2380

2014

  1. Hairy cell leukemia treated initially with purine analogs: A retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC)

    Leukemia and Lymphoma, Vol. 55, Núm. 5, pp. 1007-1012

  2. Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: New criteria for differential diagnosis and risk stratification

    Leukemia, Vol. 28, Núm. 1, pp. 166-173

2012

  1. Response to imatinib mesylate in patients with hypereosinophilic syndrome

    International Journal of Hematology, Vol. 96, Núm. 3, pp. 320-326

2011

  1. The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis

    Blood, Vol. 117, Núm. 13, pp. 3613-3616

2008

  1. Reacciones adversas relacionadas con la administración de inhibidores del TNF. Análisis de un registro de terapias biológicas

    Reumatologia Clinica, Vol. 4, Núm. 3, pp. 90-95

2005

  1. Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer

    Investigational New Drugs, Vol. 23, Núm. 3, pp. 243-251

2004

  1. Experiencia del Hospital Universitario de Salamanca en el tratamiento sistémico adyuvante del cáncer de mama locorregional. Resultados de un protocolo asistencial tras 7 años de seguimiento

    Oncologia, Vol. 27, Núm. 3, pp. 28-38

2003

  1. A multicenter phase II study of irinotecan in patients with advanced colorectal cancer previously treated with 5-fluorouracil

    Clinical Colorectal Cancer, Vol. 3, Núm. 3, pp. 174-179

  2. Immunophenotypic analysis of Waldenstrom's macroglobulinemia

    Seminars in Oncology, Vol. 30, Núm. 2, pp. 187-195